{
    "1706278835694567545": {
        "author_id": "194037150",
        "created_at": "2023-09-25T12:05:50.000Z",
        "edit_history_tweet_ids": [
            "1706278835694567545"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 5,
                    "normalized_text": "PRESS",
                    "probability": 0.371,
                    "start": 1,
                    "type": "Organization"
                },
                {
                    "end": 17,
                    "normalized_text": "Valo Health",
                    "probability": 0.5706,
                    "start": 7,
                    "type": "Organization"
                },
                {
                    "end": 34,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.4957,
                    "start": 23,
                    "type": "Organization"
                }
            ],
            "hashtags": [
                {
                    "end": 6,
                    "start": 0,
                    "tag": "PRESS"
                }
            ]
        },
        "id": "1706278835694567545",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 10474,
            "like_count": 61,
            "quote_count": 4,
            "reply_count": 5,
            "retweet_count": 4
        },
        "text": "#PRESS Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence"
    }
}